Longevity Technology

What Longevity Technology does

Longevity.Technology, operated by First Longevity Ltd and headquartered in Newbury, Berkshire with an additional office in Oxford, has transformed from a longevity-focused daily news and podcast media outlet into an AI-native data infrastructure company serving the global longevity sector. Its core product is DLT (Decoding Longevity Trends), an intelligence platform tracking more than 700 longevity and age-related disease biotechs via an agentic AI discovery engine, independent LLM fact-checking, and a chatbot interface; the first module, DLT Biotech, covers more than 600 companies with detailed profiles, clinical asset analysis, and market intelligence. The company also operates supporting media and commerce properties including a daily newsletter, the Longevity.Technology Unlocked podcast, a global longevity clinic directory, the FLT (Fueling Longevity Today) supplement brand sold via flt.life, and a co-founded annual event, The Longevity Show (debuting June 2026 at Tobacco Dock, London) jointly owned with Founders Forum Group.

Revenue is generated through multiple streams: enterprise-level subscriptions to the DLT platform (serving investors, pharma companies, and biotech operators), individual monthly and annual subscriptions to news and analysis with auto-renewal, advertising and sponsored content on the news platform, and direct-to-consumer sales of proprietary FLT supplements including MUSCLE and COGNITION products. The go-to-market is hybrid: B2B enterprise sales for DLT (with named partners AND Capital Ventures and an unnamed Top-10 Big Pharma) alongside B2C audience development via newsletter, podcast, social channels, and the annual event. The company was founded by Phil Newman, who serves as CEO; a $70,000,000 funding round led by Seveno Capital closed in September 2025 to support expansion across the data, media, supplement, and event verticals.

Name

Longevity Technology

Legal name

Longevity Technology

Website

https://www.longevity.technology/

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

Longevity Technology is a daily news and insights on research, investments and technologies that extend life.

Ownership category

akta.pro rank

Product category

Longevity Data Intelligence and Media

NAICS

Software Publishers (5132), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Healthy Aging & Cognitive Support Supplements (CRADAGAM)

akta.pro secondary industries

Health & Wellness (Vitamins, Supplements, OTC) DTC (CRAFACAC), Healthy Aging & Longevity Lifestyle Coaching (HSADAGAK)

Keywords

• Longevity data intelligence
• Longevity media publishing
• Longevity supplements
• Biotech industry research
• Longevity event production

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

1. Corporate Subscriptions (DLT Platform): Enterprise-level subscriptions for the DLT data intelligence platform providing deal flow, market insights, due diligence support, and investor education to pharma companies, investors, and biotech operators.
2. Individual Subscriptions: Monthly and annual subscription services for individual access to longevity news, analysis, and content. Auto-renewal enabled with monthly (30-day) and annual (365-day) terms.
3. Advertising: The platform hosts advertising and sponsored content, with advertiser partnerships for reaching longevity industry audience.
4. FLT Supplements Sales: Sale of proprietary supplement products (MUSCLE, COGNITION, FLT) through the FLT.life storefront, including subscription-based auto-replenishment options.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Longevity.Technology runs the DLT (Decoding Longevity Trends) data intelligence platform covering longevity research, clinical trials, investors, companies and clinics, primarily sold to institutional clients in pharma, biotech and investment. It also operates a longevity-focused media network (news site, podcast and clinics directory), an annual flagship event (The Longevity Show), and a consumer supplements brand (FLT) with MUSCLE and COGNITION product lines.

Product overview

Longevity.Technology operates as a multi-faceted longevity intelligence platform. The core product is DLT (Decoding Longevity Trends), an AI-native data infrastructure platform with its first module DLT Biotech tracking over 600 longevity-focused biotech companies. Supporting this are media properties including a news platform delivering daily longevity briefings, the Longevity.Technology Unlocked podcast, and a global longevity clinics directory. The company also co-founded The Longevity Show (launching June 2026), a platform combining professional conferences with consumer exhibitions for the longevity movement.

Differentiator

Problem solved

Functional benefit

Brands

• The Longevity Show: A consumer longevity movement platform featuring a professional business conference and consumer exhibition, co-founded with Founders Forum Group.
• DLT (Decoding Longevity Trends)
• FLT (Fueling Longevity Today)

Products and services

• DLT (Decoding Longevity Trends)

Quantifiable outcome

• 2024 longevity sector financing reached $8.49 billion across 325 deals
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• AND Capital VenturescoreStrategic or Co-development Partner · 5 May 2026Strategic partnership making Longevity.Technology's AI-enabled DLT platform a key intelligence and deal-flow resource for AND Capital's health and wellness investment strategy. The collaboration provides curated deal flow, market insights, due diligence support, and investor education focused on longevity and healthspan innovation. Both parties expect the partnership to expand iteratively as additional strategies, funds, and portfolio platforms come online.
• L-NutraminorGTM or Marketing Partner · 23 February 2026L-Nutra named Innovator Partner for The Longevity Show 2026. Precision nutrition company specializing in fasting-mimicking technology and longevity programs, having partnered with 18 global university research centers, conducted 47 clinical trials, and holding 137 granted patents.
• NADclinicminorGTM or Marketing Partner · 20 January 2026NADclinic named Innovator Partner for The Longevity Show 2026. With over a decade of NAD+ expertise and operations spanning 40+ countries, NADclinic offers NAD+ injectables, diagnostics, and nutraceuticals through scalable solutions for premium venues.
• International Institute of LongevityminorStrategic or Co-development Partner · 1 December 2025Longevity.Technology founder Phil Newman and team surveyed 82 longevity clinics across US, Australia, Brazil, and multiple European and Asian countries. Collaboration on Global Survey on Longevity, Health & Wellbeing initiative to identify key trends, challenges, and opportunities shaping the longevity sector.
• Founders Forum GroupcoreStrategic or Co-development Partner · 16 October 2025Co-founding of The Longevity Show, a new independent platform dedicated to the consumer longevity movement. Jointly owned by Founders Forum LLP and Longevity.Technology, combining expertise in innovation ecosystems and longevity sector coverage. The Longevity Show debuted June 26-27, 2026 at Tobacco Dock, London, featuring both professional business conference and consumer exhibition.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• BioCentury: Long-running subscription intelligence and news service for biotech developers, investors, and pharma BD teams. Directly comparable to Longevity.Technology's combination of DLT intelligence plus editorial coverage for a specialized life-sciences audience.
• STAT News: Subscription-based biotech and life-sciences newsroom covering R&D, clinical, and business developments with both B2B and B2C distribution. Mirrors Longevity.Technology's daily longevity news, podcast, and paid subscriber model targeting science-curious professionals.
• Endpoints News: Biotech business and R&D news outlet with a paid subscription tier covering pipeline, deals, and industry analysis. Comparable to Longevity.Technology in providing deal-flow-relevant intelligence to pharma BD and investor audiences in life sciences.
• Inside Precision Medicine: News and analysis platform covering precision medicine, aging research, and biotech innovation, with a similar editorial-plus-events presence. Directly comparable to Longevity.Technology's daily news, newsletters, and conference-style activations in the longevity medicine niche.
• Life Extension: Long-standing longevity-focused media brand and DTC supplement retailer offering vitamins and healthy-aging products. Comparable to Longevity.Technology's combined editorial/news presence (longevity science, investment) plus FLT supplement DTC store.
• American Academy of Anti-Aging Medicine (A4M / World Health Congress): Educational organization running longevity and anti-aging conferences, exhibitions, and certifications for clinicians and consumers. Comparable to Longevity.Technology's The Longevity Show (co-founded with Founders Forum Group) as a B2B/B2C longevity conference platform.

Broad incumbents

• CB Insights: Market intelligence platform using AI-driven data on private companies, deals, and emerging technologies including health and biotech. Comparable to DLT as an enterprise intelligence subscription, but broader in scope and without Longevity.Technology's biology/longevity specialization.
• PitchBook: Comprehensive private-market data platform covering venture, PE, and M&A deal flow across sectors including biotech/healthcare. Comparable to DLT as enterprise data infrastructure for investors, though PitchBook is generalist while DLT is vertically specialized in longevity.
• Drug Discovery & Development: Established trade publication covering drug discovery, biotech, and pharma R&D with editorial content and industry resources. Comparable as a specialized media outlet serving longevity/healthspan-adjacent biotech professionals.

Others

• L-Nutra: Precision nutrition company specializing in fasting-mimicking diets and longevity nutrition, with patents and university clinical partnerships. Comparable as a longevity ecosystem partner (Innovator Partner for The Longevity Show 2026) and adjacent player serving the same healthspan consumer audience as FLT supplements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/LongevityTech
• YouTubeyoutube.com/@longevity.technology
• Facebookfacebook.com/LongevityTech
• LinkedInlinkedin.com/company/35514147/admin/dashboard
• Instagraminstagram.com/longevity.technology

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Longevity Technology